Our findings also highlight the RNA-Seq-determined, perturbed mRNA expressions which were common between SNDX-50469-treated AML cells with MLL1-r (MOLM13) and mtNPM1 (OCI-AML3). Here, RUNX2 is linked to acute myeloid leukemia.